Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
DRUG

BRIGHT MINDS BIOSCIENCES (DRUG) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $54.05 +3.9% on the day -12.0% over 12 months 52-week range $48.25 – $95.98

Share price and insider trades

DRUG closeInsider buyInsider sale
406080100NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $9,785,124 on 2026-04-28 · Cormorant Asset Management, Lp
Bought, 12 months$0
Sold, 12 months$9.8M
Insiders buying0
Insiders selling1

BRIGHT MINDS BIOSCIENCES insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $9.8M of DRUG stock on the open market.

DRUG insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $9.8M sold (1 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$9.8M1

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.5×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 BRIGHT MINDS BIOSCIENCES INC. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $9.8M. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Apr 30SEC Cormorant Asset Management, LpFormer 10% Owner Sell 109,331950,000 held (−10%) $89.50 $9.8M -39.6% —

Insiders at BRIGHT MINDS BIOSCIENCES INC.

InsiderBoughtSoldLast filingScore
Cormorant Asset Management, LpFormer 10% Owner — $9.8M Apr 30, 2026 —

DRUG stock: common questions

Are BRIGHT MINDS BIOSCIENCES INC. insiders buying DRUG stock?

In the past 12 months, 0 insiders reported open-market purchases of DRUG worth $0.

Are BRIGHT MINDS BIOSCIENCES INC. insiders selling DRUG stock?

1 insiders reported sales worth $9.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is DRUG's 52-week range?

Over the past year DRUG has traded between $48.25 and $95.98. It last closed at $54.05 on Oct 9, 2026.